Pancreatic polypeptide (PP) is a satiety-inducing gut hormone targeting predominantly the Y4 receptor within the neuropeptide Y multiligand/multireceptor family. Palmitoylated PP-based ligands have already been reported to exert prolonged satiety-inducing effects in animal models. Here, we suggest that other lipidation sites and different fatty acid chain lengths may affect receptor selectivity and metabolic stability. Activity tests revealed significantly enhanced potency of long fatty acid conjugates on all four Y receptors with a preference of position 22 over 30 at Y1 , Y2 and Y5 receptors. Improved Y receptor selectivity was observed for two short fatty acid analogues. Moreover, [K(30)(E-Prop)]hPP2-36 (15) displayed enhanced stability in blood plasma and liver homogenates. Thus, short chain lipidation of hPP at key residue 30 is a promising approach for anti-obesity therapy because of maintained selectivity and a sixfold increased plasma half-life.
n class="Gene">Pancreatic polypeptide (PP) is a satiety-inducing gut hormonpan>e targeting predominanpan>tly the Y4 receptor within the pan> class="Gene">neuropeptide Y multiligand/multireceptor family. Palmitoylated PP-based ligands have already been reported to exert prolonged satiety-inducing effects in animal models. Here, we suggest that other lipidation sites and different fatty acid chain lengths may affect receptor selectivity and metabolic stability. Activity tests revealed significantly enhanced potency of long fatty acid conjugates on all four Y receptors with a preference of position 22 over 30 at Y1 , Y2 and Y5 receptors. Improved Y receptor selectivity was observed for two shortfatty acid analogues. Moreover, [K(30)(E-Prop)]hPP2-36 (15) displayed enhanced stability in blood plasma and liver homogenates. Thus, short chain lipidation of hPP at key residue 30 is a promising approach for anti-obesity therapy because of maintained selectivity and a sixfold increased plasma half-life.
Authors: Kjeld Madsen; Lotte Bjerre Knudsen; Henrik Agersoe; Per Franklin Nielsen; Henning Thøgersen; Michael Wilken; Nils Langeland Johansen Journal: J Med Chem Date: 2007-11-02 Impact factor: 7.446
Authors: Liuyin Zhang; Charles R Robertson; Brad R Green; Timothy H Pruess; H Steve White; Grzegorz Bulaj Journal: J Med Chem Date: 2009-03-12 Impact factor: 7.446
Authors: Brian P Ward; Nickki L Ottaway; Diego Perez-Tilve; Dejian Ma; Vasily M Gelfanov; Matthias H Tschöp; Richard D Dimarchi Journal: Mol Metab Date: 2013-09-05 Impact factor: 7.422
Authors: Michael Haack; Sebastian Enck; Harald Seger; Armin Geyer; Annette G Beck-Sickinger Journal: J Am Chem Soc Date: 2008-06-05 Impact factor: 15.419
Authors: Xavier Pedragosa-Badia; Gregory R Sliwoski; Elizabeth Dong Nguyen; Diana Lindner; Jan Stichel; Kristian W Kaufmann; Jens Meiler; Annette G Beck-Sickinger Journal: J Biol Chem Date: 2013-12-27 Impact factor: 5.157
Authors: V Thieme; N Jolly; A N Madsen; K Bellmann-Sickert; T W Schwartz; B Holst; H M Cox; A G Beck-Sickinger Journal: Br J Pharmacol Date: 2016-10-05 Impact factor: 8.739
Authors: Stanislav M Cherepanov; Shigeru Yokoyama; Akira Mizuno; Wataru Ichinose; Olga Lopatina; Anna A Shabalova; Alla B Salmina; Yasuhiko Yamamoto; Hiroshi Okamoto; Satoshi Shuto; Haruhiro Higashida Journal: Pharmacol Res Perspect Date: 2017-01-17
Authors: Gregory Sliwoski; Mario Schubert; Jan Stichel; David Weaver; Annette G Beck-Sickinger; Jens Meiler Journal: PLoS One Date: 2016-06-13 Impact factor: 3.240